Zoo Pharma Dynamics possesses four formulations that are presently awaiting patent approval and are trademarked as CPP. Currently, ZPD is actively engaged in the new drug approval process with the FDA/CVM, employing open INADE and ONADE files. Our researchers have discovered that lichen extracts facilitate the degradation of PrPTSE within brain homogenate (A) as well as cause degradation of PrP in (B) a CWD-infected white-tailed deer.
Through our rigorous field trial protocols, we consistently conduct research and development to develop effective treatments for cervids infected with the Prion disease CWD. This allows us to stay at the forefront of innovative solutions in our ongoing efforts to combat this disease.